Analyst Consensus ?
ConsensusBuy36 ratings
Bullish2672.2%
Neutral1027.8%
Bearish00.0%
FN2 Earnings Intelligence
Charles River Laboratories International, Inc. analyst ratings
Charles River Laboratories International, Inc. (CRL) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$273.11Current
$151Low
$281.07Average
$465High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 15, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | Outperform | Outperform | Maintain | Sep 11, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 10, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 7, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 6, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | Aug 6, 2026 |
| CLSA | Hold | Outperform | Downgrade | Jul 20, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Jul 13, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 8, 2026 |
| UBS | Neutral | Neutral | Maintain | Feb 25, 2026 |
| Citigroup | Buy | Buy | Maintain | Jan 16, 2026 |
| Baird | Outperform | Neutral | Upgrade | Nov 6, 2025 |
| William Blair | Outperform | Market Perform | Upgrade | Oct 6, 2025 |
| Jefferies | Buy | Hold | Upgrade | Sep 9, 2025 |
| Redburn Atlantic | Buy | Neutral | Upgrade | May 23, 2025 |
| Goldman Sachs | Neutral | Buy | Downgrade | Mar 21, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Dec 13, 2024 |
| Argus Research | Hold | Buy | Downgrade | Jun 28, 2024 |
| Guggenheim | Neutral | Buy | Downgrade | Feb 15, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 22, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | May 12, 2023 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 14, 2022 |
| Keybanc | Overweight | Overweight | Maintain | May 5, 2022 |
| Stephens & Co. | Overweight | Overweight | Maintain | Apr 7, 2022 |
| Truist Securities | Buy | Buy | Maintain | May 25, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 8, 2020 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Feb 18, 2020 |
| CFRA | Strong Buy | Strong Buy | Maintain | Feb 11, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Oct 18, 2019 |
| Raymond James | Outperform | Outperform | Maintain | Nov 8, 2018 |
| Argus | Buy | Buy | Maintain | Aug 27, 2018 |
| Mitsubishi UFJ | Neutral | Neutral | Maintain | Apr 20, 2018 |
| Gabelli & Co. | Buy | Buy | Maintain | Apr 26, 2016 |
| Edward Jones | Buy | Neutral | Upgrade | May 4, 2015 |
| Cantor Fitzgerald | Buy | Buy | Maintain | Oct 1, 2013 |
| Sterne Agee | Buy | Buy | Maintain | Jun 11, 2013 |
| ISI Group | Neutral | Neutral | Maintain | Feb 20, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $273.11. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $320 | $277.18 | +17.2% | Sep 11, 2026 |
| Piper Sandler | Analyst unavailable | $300 | $269.64 | +9.8% | Aug 10, 2026 |
| Mizuho Securities | Analyst unavailable | $264 | $267.49 | -3.3% | Aug 10, 2026 |
| Morgan Stanley | Analyst unavailable | $300 | $264.05 | +9.8% | Aug 7, 2026 |
| Robert W. Baird | Analyst unavailable | $291 | $258.92 | +6.6% | Aug 6, 2026 |
| RBC Capital | Analyst unavailable | $282 | $260.72 | +3.3% | Aug 6, 2026 |
| Barclays | Analyst unavailable | $300 | $260.72 | +9.8% | Aug 5, 2026 |
| Mizuho Securities | Analyst unavailable | $230 | $233.41 | -15.8% | Jul 13, 2026 |
| Morgan Stanley | Analyst unavailable | $260 | $223.96 | -4.8% | Jul 9, 2026 |
| Bernstein | Analyst unavailable | $250 | $226.79 | -8.5% | Jul 1, 2026 |
| Morgan Stanley | Analyst unavailable | $220 | $184.79 | -19.4% | Jun 17, 2026 |
| CLSA | Analyst unavailable | $219 | $181.34 | -19.8% | May 29, 2026 |
| Robert W. Baird | Eric Coldwell | $213 | $175.56 | -22.0% | May 8, 2026 |
| Evercore ISI | Analyst unavailable | $220 | $176.32 | -19.4% | May 8, 2026 |
| Mizuho Securities | Analyst unavailable | $192 | $181.68 | -29.7% | May 8, 2026 |
| Barclays | Luke Sergott | $220 | $181.68 | -19.4% | May 8, 2026 |
| Barclays | Luke Sergott | $210 | $178.34 | -23.1% | Apr 14, 2026 |
| RBC Capital | Analyst unavailable | $215 | $178.34 | -21.3% | Apr 14, 2026 |
| Mizuho Securities | Analyst unavailable | $175 | $164.24 | -35.9% | Feb 20, 2026 |
| Robert W. Baird | Eric Coldwell | $193 | $158.18 | -29.3% | Feb 19, 2026 |
| Barclays | Luke Sergott | $200 | $158 | -26.8% | Feb 19, 2026 |
| Robert W. Baird | Analyst unavailable | $231 | $221.69 | -15.4% | Jan 13, 2026 |
| Evercore ISI | Analyst unavailable | $260 | $225.11 | -4.8% | Jan 13, 2026 |
| Robert W. Baird | Eric Coldwell | $224 | $219.49 | -18.0% | Jan 9, 2026 |
| Mizuho Securities | Ann Hynes | $215 | $215.51 | -21.3% | Jan 9, 2026 |
| Mizuho Securities | Analyst unavailable | $200 | $195.98 | -26.8% | Dec 18, 2025 |
| Barclays | Analyst unavailable | $215 | $192.97 | -21.3% | Dec 15, 2025 |
| Morgan Stanley | Kallum Titchmarsh | $185 | $176.09 | -32.3% | Dec 1, 2025 |
| Argus Research | Analyst unavailable | $200 | $166.73 | -26.8% | Nov 17, 2025 |
| Mizuho Securities | Ann Hynes | $174 | $174.95 | -36.3% | Oct 17, 2025 |
| Evercore ISI | Elizabeth Anderson | $200 | $181.18 | -26.8% | Oct 3, 2025 |
| Barclays | Luke Sergott | $195 | $170.48 | -28.6% | Oct 2, 2025 |
| Jefferies | Analyst unavailable | $195 | $157.38 | -28.6% | Sep 9, 2025 |
| Barclays | Luke Sergott | $205 | $193.14 | -24.9% | Oct 15, 2024 |
| Redburn Partners | Jamie Clark | $151 | $192.97 | -44.7% | Oct 14, 2024 |
| Mizuho Securities | Ann Hynes | $210 | $206.44 | -23.1% | Sep 17, 2024 |
| Deutsche Bank | Justin Bowers | $240 | $200.34 | -12.1% | Aug 8, 2024 |
| Robert W. Baird | Eric Coldwell | $239 | $201.85 | -12.5% | Jul 10, 2024 |
| Barclays | Luke Sergott | $230 | $207.35 | -15.8% | Jun 28, 2024 |
| Goldman Sachs | Matthew Sykes | $290 | $216.12 | +6.2% | Jun 6, 2024 |
| Evercore ISI | Elizabeth Anderson | $265 | $230.09 | -3.0% | May 9, 2024 |
| Evercore ISI | Elizabeth Anderson | $300 | $270.95 | +9.8% | Apr 1, 2024 |
| KeyBanc | Donald Hooker | $300 | $257.51 | +9.8% | May 5, 2022 |
| Wells Fargo | Analyst unavailable | $325 | $257.75 | +19.0% | Apr 25, 2022 |
| Jefferies | David Windley | $280 | $273.03 | +2.5% | Apr 25, 2022 |
| Jefferies | David Windley | $464 | $357.95 | +69.9% | Jan 11, 2022 |
| Argus Research | David Toung | $440 | $377.51 | +61.1% | Nov 24, 2021 |
| Cowen & Co. | Daniel Brennan | $465 | $417.45 | +70.3% | Aug 17, 2021 |
| Credit Suisse | Katie Tryhane | $385 | $416.31 | +41.0% | Aug 4, 2021 |
| J.P. Morgan | Tycho Peterson | $390 | $337.99 | +42.8% | May 28, 2021 |
| Guggenheim | Sandy Draper | $369 | $329.52 | +35.1% | May 25, 2021 |
Track every rating change on CRL the moment it posts. Free to start.
Start free